Overview Dividends

(CROX) Crocs - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2270461096

Clogs, Sandals, Sneakers, Slides, Boots

Footwear
Market Cap in USD: 4,387m

IPO / Inception: 2006-02-08
Return 12m vs S&P 500: -29.9%

EPS (Earnings per Share)

EPS CAGR: 8.51%
EPS Trend: 52.3%

Last SUE: 2.59
Qual. Beats: 15

Revenue

Rev. CAGR: 15.17%
Rev. Trend: 64.5%

Last SUE: 1.95
Qual. Beats: 1

Dividends

Currently no dividends paid

Risk via 10d forecast
Volatility	47.7%
Value at Risk 5%th	64.4%
Relative Tail Risk	-17.87%

Reward TTM
Sharpe Ratio	-0.12
Alpha	-39.09
CAGR/Max DD	-0.12

Character TTM
Hurst Exponent	0.631
Beta	1.141
Beta Downside	0.510

Drawdowns 3y
Max DD	54.04%
Mean DD	26.62%
Median DD	30.47%

Description: CROX Crocs November 06, 2025

Crocs, Inc. (NASDAQ:CROX) designs, manufactures, markets and distributes casual-lifestyle footwear and accessories for men, women and children under the Crocs and HEYDUDE brands. Its product slate spans clogs, sandals, platforms, wedges, boots, slides, flip-flops, sneakers, slippers and complementary items such as beads, straps, bags and socks, sold through a mix of wholesale partners, company-owned retail stores, e-commerce sites, third-party marketplaces and kiosk-in-store concepts.

Key recent metrics: FY 2024 revenue reached roughly $2.2 billion, with a gross margin of about 45% and direct-to-consumer sales growing ~18% YoY, driven largely by online traffic and a stronger HEYDUDE contribution. The global casual-footwear market is expanding at ~3% CAGR, while discretionary consumer spending remains sensitive to inflation and employment trends-both of which can materially affect Crocs’ top line.

For a deeper quantitative assessment, you might explore ValueRay’s CROX valuation dashboard to see how these drivers are reflected in the current price target.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (182.5m TTM) > 0 and > 6% of Revenue (6% = 244.4m TTM)

FCFTA 0.17 (>2.0%) and ΔFCFTA -3.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 6.86% (prev 7.31%; Δ -0.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.18 (>3.0%) and CFO 779.8m > Net Income 182.5m (YES >=105%, WARN >=100%)

Net Debt (1.55b) to EBITDA (378.2m) ratio: 4.10 <= 3.0 (WARN <= 3.5)

Current Ratio 1.40 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (55.2m) change vs 12m ago -7.28% (target <= -2.0% for YES)

Gross Margin 59.08% (prev 58.15%; Δ 0.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 90.38% (prev 86.41%; Δ 3.97pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.67 (EBITDA TTM 378.2m / Interest Expense TTM 180.9m) >= 6 (WARN >= 3)

Altman Z'' 4.63

(A) 0.06 = (Total Current Assets 971.2m - Total Current Liabilities 691.7m) / Total Assets 4.30b

(B) 0.79 = Retained Earnings (Balance) 3.38b / Total Assets 4.30b

(D) 1.14 = Book Value of Equity 3.33b / Total Liabilities 2.94b

Total Rating: 4.63 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 65.66

1. Piotroski 5.0pt

2. FCF Yield 12.06%

3. FCF Margin 17.59%

4. Debt/Equity 1.25

5. Debt/Ebitda 4.10

6. ROIC - WACC (= -1.11)%

7. RoE 11.08%

8. Rev. Trend 64.53%

9. EPS Trend 52.31%

What is the price of CROX shares?

As of November 29, 2025, the stock is trading at USD 84.98 with a total of 759,589 shares traded.
Over the past week, the price has changed by +4.35%, over one month by -2.03%, over three months by -1.52% and over the past year by -19.53%.

Is CROX a buy, sell or hold?

Crocs has received a consensus analysts rating of 4.20. Therefore, it is recommended to buy CROX.

Strong Buy: 7
Buy: 4
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CROX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	89.5	5.3%
Analysts Target Price	89.5	5.3%
ValueRay Target Price	81.9	-3.6%

CROX Fundamental Data Overview November 26, 2025

Market Cap USD = 4.39b (4.39b USD * 1.0 USD.USD)
P/E Trailing = 27.8924
P/E Forward = 7.4019
P/S = 1.0773
P/B = 3.1017
P/EG = -31.83
Beta = 1.542
Revenue TTM = 4.07b USD
EBIT TTM = 301.9m USD
EBITDA TTM = 378.2m USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 84.3m USD (from shortTermDebt, last quarter)
Debt = 1.71b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b USD (from netDebt column, last quarter)
Enterprise Value = 5.94b USD (4.39b + Debt 1.71b - CCE 154.0m)
Interest Coverage Ratio = 1.67 (Ebit TTM 301.9m / Interest Expense TTM 180.9m)
FCF Yield = 12.06% (FCF TTM 716.2m / Enterprise Value 5.94b)
FCF Margin = 17.59% (FCF TTM 716.2m / Revenue TTM 4.07b)
Net Margin = 4.48% (Net Income TTM 182.5m / Revenue TTM 4.07b)
Gross Margin = 59.08% ((Revenue TTM 4.07b - Cost of Revenue TTM 1.67b) / Revenue TTM)
Gross Margin QoQ = 58.52% (prev 61.67%)
Tobins Q-Ratio = 1.38 (Enterprise Value 5.94b / Total Assets 4.30b)
Interest Expense / Debt = 6.58% (Interest Expense 112.3m / Debt 1.71b)
Taxrate = 23.02% (43.6m / 189.4m)
NOPAT = 232.4m (EBIT 301.9m * (1 - 23.02%))
Current Ratio = 1.40 (Total Current Assets 971.2m / Total Current Liabilities 691.7m)
Debt / Equity = 1.25 (Debt 1.71b / totalStockholderEquity, last quarter 1.36b)
Debt / EBITDA = 4.10 (Net Debt 1.55b / EBITDA 378.2m)
Debt / FCF = 2.17 (Net Debt 1.55b / FCF TTM 716.2m)
Total Stockholder Equity = 1.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 182.5m / Total Assets 4.30b)
RoE = 11.08% (Net Income TTM 182.5m / Total Stockholder Equity 1.65b)
RoCE = 10.18% (EBIT 301.9m / Capital Employed (Equity 1.65b + L.T.Debt 1.32b))
RoIC = 7.67% (NOPAT 232.4m / Invested Capital 3.03b)
WACC = 8.78% (E(4.39b)/V(6.09b) * Re(10.22%) + D(1.71b)/V(6.09b) * Rd(6.58%) * (1-Tc(0.23)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.88%
[DCF Debug] Terminal Value 72.84% ; FCFE base≈805.8m ; Y1≈910.5m ; Y5≈1.23b
Fair Price DCF = 286.0 (DCF Value 14.85b / Shares Outstanding 51.9m; 5y FCF grow 15.10% → 3.0% )
EPS Correlation: 52.31 | EPS CAGR: 8.51% | SUE: 2.59 | # QB: 15
Revenue Correlation: 64.53 | Revenue CAGR: 15.17% | SUE: 1.95 | # QB: 1

Additional Sources for CROX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle